{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:18:01Z","timestamp":1786987081860,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.colsurfb.2018.11.022","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T02:50:49Z","timestamp":1541991049000},"page":"582-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Thin polymeric films for the topical delivery of propranolol"],"prefix":"10.1016","volume":"174","author":[{"given":"Cristina","family":"Padula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-0957","authenticated-orcid":false,"given":"Sara","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pescina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7601-7894","authenticated-orcid":false,"given":"Patrizia","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2018.11.022_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14963","article-title":"Topical propranolol for infantile haemangiomas: a systematic review","author":"Price","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"24","key":"10.1016\/j.colsurfb.2018.11.022_bib0010","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2018.11.022_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bcp.12235","article-title":"The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies","volume":"78","author":"Lou","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MOP.0000000000000650","article-title":"Infantile hemangiomas: what have we learned from propranolol?","author":"Hagen","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"issue":"12","key":"10.1016\/j.colsurfb.2018.11.022_bib0025","first-page":"1185","article-title":"Infantile hemangioma: pathogenesis and mechanisms of action of propranolol","volume":"15","author":"Rotter","year":"2017","journal-title":"J. Dermatol. Ges."},{"issue":"6","key":"10.1016\/j.colsurfb.2018.11.022_bib0030","first-page":"5","article-title":"Treatment of infantile hemangiomas with beta-blockers: a review","volume":"18","author":"Shah","year":"2013","journal-title":"Skin Therapy Lett."},{"issue":"6","key":"10.1016\/j.colsurfb.2018.11.022_bib0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3783","article-title":"Safety of oral propranolol for infantile hemangioma","volume":"141","author":"Droitcourt","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0040","article-title":"Infantile hemangiomas: confirmed safety of oral propranolol","volume":"222","author":"Lorenz","year":"2018","journal-title":"Z. Geburtshilfe Neonatol."},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0045","first-page":"E17","article-title":"Expanding uses of propranolol in dermatology","volume":"99","author":"Oberlin","year":"2017","journal-title":"Cutis"},{"issue":"8","key":"10.1016\/j.colsurfb.2018.11.022_bib0050","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/SCS.0000000000004166","article-title":"Propranolol treatment of vascular anomalies other than infantile hemangioma","volume":"28","author":"Goss","year":"2017","journal-title":"J. Craniofac. Surg."},{"issue":"3","key":"10.1016\/j.colsurfb.2018.11.022_bib0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dth.12328","article-title":"Topical propranolol for a chronic recalcitrant wound","volume":"29","author":"Vestita","year":"2016","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2018.11.022_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/pde.13372","article-title":"Topical 1% propranolol ointment with occlusion in treatment of pyogenic granulomas: an open-label study in 22 children","volume":"35","author":"Neri","year":"2018","journal-title":"Pediatr. Dermatol."},{"issue":"1-7","key":"10.1016\/j.colsurfb.2018.11.022_bib0065","first-page":"1687","article-title":"Oral versus topical propranolol for management of superficial infantile hemangiomas: a comparative study","volume":"13","author":"Safy","year":"2017","journal-title":"Ann. Pediatr. Surg."},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0070","first-page":"75","article-title":"Topical propranolol cream in treatment of superficial infantile hemangiomas: a literature review and 4 years of clinical experience","volume":"23","author":"Kovacevic","year":"2014","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0075","first-page":"185","article-title":"Propranolol in rapidly growing hemangiomas","volume":"18","author":"Bonifazi","year":"2008","journal-title":"Eur. J. Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.colsurfb.2018.11.022_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.XPS.0000482654.21247.63","article-title":"Oral versus topical propranolol for management of superficial infantile hemangiomas: a comparative study","volume":"13","author":"Abdel Wahab","year":"2017","journal-title":"Ann. Pediatr. Surg."},{"issue":"6-7","key":"10.1016\/j.colsurfb.2018.11.022_bib0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.annder.2013.04.085","article-title":"[Rapid regression of infantile haemangioma with 2% propranolol ointment]","volume":"140","author":"Mouhari-Toure","year":"2013","journal-title":"Ann. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.colsurfb.2018.11.022_bib0090","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaad.2012.03.009","article-title":"Topical propranolol for treatment of superficial infantile hemangiomas","volume":"67","author":"Xu","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.colsurfb.2018.11.022_bib0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1470.2011.01615.x","article-title":"Topical propranolol therapy for infantile hemangiomas","volume":"29","author":"Kunzi-Rapp","year":"2012","journal-title":"Pediatr. Dermatol."},{"issue":"6","key":"10.1016\/j.colsurfb.2018.11.022_bib0100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11596-012-1059-6","article-title":"Topical propranolol hydrochloride gel for superficial infantile hemangiomas","volume":"32","author":"Wang","year":"2012","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12519-014-0509-6","article-title":"Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas","volume":"10","author":"Schneider","year":"2014","journal-title":"World J. Pediatr."},{"issue":"7","key":"10.1016\/j.colsurfb.2018.11.022_bib0110","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3109\/03639045.2014.931968","article-title":"Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma","volume":"41","author":"Zhou","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000447672","article-title":"Topical treatment of infantile haemangiomas: a comparative study on the selection of a semi-solid vehicle","volume":"29","author":"Casiraghi","year":"2016","journal-title":"Skin Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.colsurfb.2018.11.022_bib0120","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.24390","article-title":"Evaluation of beta-blocker gel and effect of dosing volume for topical delivery","volume":"104","author":"Zhang","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.colsurfb.2018.11.022_bib0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0378-5173(99)00380-4","article-title":"A comparative in vitro study of percutaneous penetration of beta-blockers in human skin","volume":"194","author":"Modamio","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.colsurfb.2018.11.022_bib0130","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jps.21891","article-title":"An investigation into the influence of counterion on the RS-propranolol and S-propranolol skin permeability","volume":"99","author":"Cilurzo","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2018.11.022_bib0135","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/mp400675d","article-title":"An insight into the skin penetration enhancement mechanism of N-methylpyrrolidone","volume":"11","author":"Cilurzo","year":"2014","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.colsurfb.2018.11.022_bib0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jps.2600820802","article-title":"Metabolism of propranolol during percutaneous absorption in human skin","volume":"82","author":"Ademola","year":"1993","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.colsurfb.2018.11.022_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-018-2495-1","article-title":"In vitro skin retention and drug permeation through intact and microneedle pretreated skin after application of propranolol loaded microemulsions","volume":"35","author":"Kelchen","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0150","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/IJN.S164404","article-title":"Development and characterization of a nanoemulsion containing propranolol for topical delivery","volume":"13","author":"Marques","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0155","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.2147\/IJN.S137634","article-title":"Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth","volume":"12","author":"Guo","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0160","first-page":"1281673","article-title":"The influence of formulation and excipients on propranolol skin permeation and retention","author":"Padula","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.colsurfb.2018.11.022_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000082572","article-title":"The mystical effects of dermatological vehicles","volume":"210","author":"Surber","year":"2005","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.colsurfb.2018.11.022_bib0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-3659(03)00015-4","article-title":"Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior","volume":"88","author":"Padula","year":"2003","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.colsurfb.2018.11.022_bib0175","first-page":"309","article-title":"Bioadhesive film for dermal and transdermal drug delivery","volume":"17","author":"Padula","year":"2007","journal-title":"Eur. J. Dermatol."},{"issue":"7","key":"10.1016\/j.colsurfb.2018.11.022_bib0180","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jps.20638","article-title":"Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan","volume":"95","author":"Femenia-Font","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"1-2","key":"10.1016\/j.colsurfb.2018.11.022_bib0185","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijpharm.2014.06.050","article-title":"Vehicle influence on permeation through intact and compromised skin","volume":"472","author":"Gujjar","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.colsurfb.2018.11.022_bib0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/bmc.1024","article-title":"Simultaneous determination of benzophenone-3, retinol and retinyl acetate in pig ear skin layers by high-performance liquid chromatography","volume":"22","author":"Padula","year":"2008","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.colsurfb.2018.11.022_bib0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000077237","article-title":"Bioadhesive transdermal film containing caffeine","volume":"17","author":"Nicoli","year":"2004","journal-title":"Skin Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.colsurfb.2018.11.022_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000056328","article-title":"Effects of skin occlusion on percutaneous absorption: an overview","volume":"14","author":"Zhai","year":"2001","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"10","key":"10.1016\/j.colsurfb.2018.11.022_bib0205","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1002\/jps.22152","article-title":"Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering","volume":"99","author":"Padula","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2018.11.022_bib0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1590\/s1984-82502016000300018","article-title":"Evaluation of skin absorption of drugs from topical and transdermal formulations","volume":"52","author":"Ruela","year":"2016","journal-title":"Braz. J. Pharm. Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518307987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776518307987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:38:57Z","timestamp":1760524737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776518307987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":42,"alternative-id":["S0927776518307987"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.022","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thin polymeric films for the topical delivery of propranolol","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2018.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}